INTRODUCTION TO DRUG DEVELOPMENT

PHMSCI 756

Provides a high-level overview of how data analysis techniques augment the drug discovery and development process. Focuses on project-based skills-building through the application of industry-standard software and use of public databases. Explores best practices for data processing and management to ensure experimental reproducibility. Develops troubleshooting skills through critical evaluation of data analysis results and root cause analysis.

PHMSCI 762

Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.

PHMSCI 763

Overview of the drug development process from first-in-human (FIH) to submission of a new drug application (NDA) or biologics license application (BLA). Phases of clinical development and the role of biomarkers, companion diagnostics, statistical analysis, and CMC in clinical trials. Both small molecule and protein therapeutics will be addressed.

PHMSCI 680

Learn about essential components of drug development and cutting-edge research in drug discovery, drug action, and drug delivery. Focus on useful and practical information and essential underpinnings in chemistry, biology, physical chemistry, and engineering.

PHMSCI 759

Provides the experience and skill to find, read and critically analyze scientific and regulatory literature in the field of drug discovery and development.